Robert Manning
Chairman @ Cherrystone Angel Group
Providence, United States
Robert Manning is a Series A investor at Cherrystone Angel Group in Providence focused on Biotechnology and Health Care. Robert Manning - President @ Gray's Point Investments LLC
- Total investments:
- 14
- Last investment:
- Lead investor:
- 79%
Last updated:
For AI agents: llms.txt
Industries Robert Manning invests in
Stages Robert Manning invests in
Countries Robert Manning invests in
Investment Focus
Industry
- Biotechnology 3 (21%)
- Health Care 2 (14%)
- Therapeutics 2 (14%)
- Medical Device 2 (14%)
- Diabetes 1 (7%)
Stage
- Series A 2 (14%)
- Convertible Note 2 (14%)
- Series B 1 (7%)
- Series C 1 (7%)
- Series D 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Respiratory Motion
|
Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. | Series C / Mar 01, 2015 | |
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | Convertible Note / Dec 01, 2014 | |
|
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | Convertible Note / Apr 01, 2014 | |
|
Respiratory Motion
|
Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. | Convertible Note / Jul 01, 2013 | |
|
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $11.5M / Series B / Jun 07, 2013 | |
|
Respiratory Motion
|
Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. | Convertible Note / Mar 01, 2013 | |
|
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $6.4M / Series B / Dec 19, 2012 | |
|
Respiratory Motion
|
Respiratory Motion is a commercial-stage medical device company that specializes in the fields of medical device, clinical evaluation and testing, manufacturing, and respiratory monitoring. The company is developing and commercializing the ExSpiron. RMI’s goal is to cost-effectively improve the standard of care in respiratory monitoring. It wasfounded in 2010 and headquartered in Watertown, Massachusetts. | Convertible Note / Aug 01, 2012 | |
|
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | Convertible Note / Jun 01, 2012 | |
|
Avaxia Biologics
|
Avaxia Biologics is a private, early-stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease, and diabetes, and obesity. Avaxia Biologics was founded in 2005 and headquartered in Lexington, Massachusetts. | $4.1M / Series A / Feb 14, 2012 | |
| See all 14 investments → | |||
Co-Investors
Beta Fund
5 deals together
Boston Harbor Angels
5 deals together
Beacon Angels
4 deals together
LaunchPad Venture
3 deals together
Mass Medical Angels
3 deals together
Golden Seeds
2 deals together
About Cherrystone Angel Group
Cherrystone Angel Group, founded in 2004 and comprised of over 60 Rhode Island members, is Rhode Island’s first organized angel investment group. Its members invest in early stage, typically pre-revenue companies, across the tri-state region. While it is the entrepreneur who drives the company — and on whom ultimate success depends —Cherrystone believes that good advice and focused expertise are vital to the success of any business venture. When Cherrystone invests, it not only brings money to the table but industry knowledge and connections that will make its business succeed. All its members are experienced and qualified investors who have either built their own companies or have extensive experience launching new business ventures. Their backgrounds include creating or working with manufacturing, distribution, technology, and service companies.
Cherrystone Angel Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Robert Manning
Chairman
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Robert Manning invest in?
Robert Manning invests primarily in Biotechnology, Health Care and Therapeutics startups, most often at Series A and Convertible Note stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Robert Manning last invest?
The most recent investment recorded for Robert Manning closed in Mar 2015. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
